Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanara MedTech Inc. Director's Dealing 2018

Jun 6, 2018

33339_dirs_2018-06-05_e1d1cbe1-4664-42b4-b10d-cf579626b37c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (wndm)
CIK: 0000714256
Period of Report: 2018-02-19

Reporting Person: STUCKERT JAMES W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-19 Common Stock J 11325678 $0.07 Acquired 22057433 Indirect
2018-02-19 Common Stock J 13037070 $0.07 Acquired 65094503 Indirect
2018-02-19 Common Stock J 3965400 $0.07 Acquired 5365400 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-19 Series C Preferred Stock $ J 36384 Disposed Common Stock (43037070) Indirect
2018-02-19 Series C Preferred Stock $ J 3572 Disposed Common Stock (3965400) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1500000 Indirect
Common Stock 835586 Indirect

Footnotes

F1: On February 19, 2018, the James W. Stuckert Revocable Trust converted all principal and interest under that certain promissory note, dated as of June 15, 2015, in the principal amount of $600,000, into 11,325,678 shares of the Company's Common Stock.

F2: On February 19, 2018, the James W. Stuckert Revocable Trust converted 36,384 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 43,037,070 shares of the Company's Common Stock.

F3: On February 19, 2018, the Diane V. Stuckert Revocable Trust converted 3,572 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 3,965,400 shares of the Company's Common Stock.

F4: The reporting person is the trustee of the trust.

F5: The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F6: The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F7: The reporting person serves as the general partner of the partnership.